Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11
Conditions
- Epidemic Parotitis, Mumps
Interventions
- BIOLOGICAL: Attenuated Mumps vaccine (KMB-17) in phase II and III
- BIOLOGICAL: Placebo in phase II
- BIOLOGICAL: Attenuated Mumps vaccine (KMB-17) in phase III
- BIOLOGICAL: Placebo in phase III
Sponsor
Institute of Medical Biology, Chinese Academy of Medical Sciences
Collaborators